Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? Giandomenico RovielloGiuseppe AprileMartina Catalano Review Article 19 March 2021 Pages: 765 - 779
Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer Kohei ShitaraEishi BabaKensei Yamaguchi Review Article Open access 16 May 2021 Pages: 780 - 789
Geographic impact on access to care and survival for non-curative esophagogastric cancer: a population-based study Elliott K. YeeNatalie G. CoburnJulie Hallet Original Article 06 February 2021 Pages: 790 - 799
Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort Willem J. KoemansRobin J. LurvinkJohanna W. van Sandick Original Article 25 January 2021 Pages: 800 - 809
Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy Takahiro IshiiAyako SuzukiGenichiro Ishii Original Article 09 April 2021 Pages: 810 - 822
Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia Deqiang WangNing WangYongqian Shu Original Article 09 March 2021 Pages: 823 - 834
A novel combination of serum microRNAs for the detection of early gastric cancer Seiichiro AbeJuntaro MatsuzakiTakahiro Ochiya Original Article Open access 20 March 2021 Pages: 835 - 843
Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study Ki Wook KimNayoung KimYoung Hoon Kim Original Article 18 February 2021 Pages: 844 - 857
Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma Lusheng SongMinkyo SongCharles S. Rabkin Original Article 04 March 2021 Pages: 858 - 867
Deep learning system for lymph node quantification and metastatic cancer identification from whole-slide pathology images Yajie HuFeng SuYu Sun Original Article 23 January 2021 Pages: 868 - 877
International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk Benjamin AschermanAaron OhChin Hur Original Article 17 February 2021 Pages: 878 - 887
Subepithelial spread of early gastric cancer is common and extends more than expected Min Kyung YeoSun Hyung KangGo Eun Bae Original Article 23 February 2021 Pages: 888 - 896
Personalized therapeutic strategies in HER2-driven gastric cancer Stefano UghettoCristina MiglioreSilvia Giordano Original Article 23 March 2021 Pages: 897 - 912
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors Yingying XuYakun WangLin Shen Original Article Open access 04 May 2021 Pages: 913 - 925
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry Felipe Alvarez-ManceñidoPaula Jimenez-FonsecaJavier Gallego Original Article 02 March 2021 Pages: 926 - 936
Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy Hidehiko TakigawaRyo YugeYasuhiko Kitadai Original Article 27 February 2021 Pages: 937 - 945
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab Narikazu BokuTaroh SatohYoon-Koo Kang Original Article Open access 20 March 2021 Pages: 946 - 958
Hospital volume following major surgery for gastric cancer determines in-hospital mortality rate and failure to rescue: a nation-wide study based on German billing data (2009–2017) J. DiersP. BaumA. Wiegering Original Article 12 February 2021 Pages: 959 - 969
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study Wasat MansoorHendrik-Tobias ArkenauEric Van Cutsem Short Communication Open access 13 March 2021 Pages: 970 - 977
Comment on: “Long‑term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer. Gastric Cancer, 2020 Nov 17” by Watanabe et al. Yaobin OuyangCong HeNonghua Lu Letter to the Editor 07 January 2021 Pages: 978 - 979
Reply to the letter by Ouyang et al. regarding our manuscript “Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer” Toshio WatanabeYuji NadataniYasuhiro Fujiwara Letter to the Editor 19 May 2021 Pages: 980 - 981